03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Rasilez HCT 300mg/25mg° : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Khalil Fattal & Fils |
Distributor | Khalil Fattal & Fils |
Laboratory | Novartis |
Responsible Party | Novartis Pharma AG |
Origin | Switzerland |
Manufacturer | Novartis Farma SPA |
Origin | Italy |
ATC | C09XA52 |
Revision Date | 01/10/2012 |
Rasilez HCT 300mg/25mg° :
Rasilez HCT 300mg/25mg° :
Rasilez HCT 300mg/25mg° :
Rasilez HCT 300mg/25mg° :
Rasilez HCT 300mg/25mg° :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Rasilez HCT 300mg/25mg° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal discomfort | Rare |
Acute hepatic failure | Not known |
Acute kidney injury | Uncommon |
Agranulocytosis | Very rare |
Alkalosis hypochloraemic | Very rare |
Anaphylactic reactions | Rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Angle closure glaucoma | Not known |
Aplastic anemia | Not known |
Arrhythmia | Rare |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Not known |
Blood cholesterol increased | Very Common |
Blood creatinine increased | Rare |
Blood potassium increased | Not known |
Blood triglycerides increased | Very Common |
Bone marrow failure | Very rare |
Cholestasis | Rare |
Constipation | Rare |
Cough | Uncommon |
Cutaneous lupus erythematosus | Very rare |
Decreased appetite | Common |
Depression | Rare |
Diabetes mellitus | Rare |
Diarrhoea (Diarrhea) | Common |
Dizziness | Common |
Dyspnoea (dyspnea) | Not known |
Erectile dysfunction | Common |
Erythema | Rare |
Erythema multiforme | Not known |
Glucosuria (Glycosuria) | Very rare |
Haematocrit decreased | Rare |
Haemoglobin decreased | Rare |
Haemolytic anemia | Very rare |
Headache | Rare |
Hepatic enzyme increased | Uncommon |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatitis | Not known |
Hypercalcaemia | Rare |
Hyperglycaemia | Rare |
Hyperkalaemia | Common |
Hypersensitivity | Rare |
Hyperuricaemia | Common |
Hypokalaemia | Very Common |
Hypomagnesaemia | Common |
Hyponatraemia (Hyponatremia) | Common |
Hypotension | Uncommon |
Jaundice | Rare |
Leucopenia (Leukopenia) | Very rare |
Lip swelling | Not known |
Liver disorder | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Uncommon |
Muscle spasms | Not known |
Nausea | Common |
Necrotizing vasculitis | Very rare |
Oedema peripheral | Uncommon |
Oral disorder | Uncommon |
Orthostatic hypotension | Common |
Palpitations | Uncommon |
Pancreatitis | Very rare |
Paraesthesia (paresthesia) | Rare |
Pharyngeal oedema | Not known |
Photosensitivity reaction | Rare |
Pneumonitis | Very rare |
Pruritus | Uncommon |
Pulmonary oedema | Very rare |
Pyrexia | Not known |
Renal impairment | Uncommon |
Respiratory distress | Very rare |
Skin rash | Common |
Skin reaction | Uncommon |
Sleep disorder (Sleep disturbance) | Rare |
Stevens-Johnson syndrome | Uncommon |
Swelling face | Not known |
Swollen tongue | Not known |
Thrombocytopenia (Thrombopenia) | Rare |
Thrombocytopenic purpura | Rare |
Urticaria | Common |
Vertigo | Not known |
Visual disturbance | Rare |
Vomiting | Common |
Rasilez HCT 300mg/25mg° :
NB : Products With Same Indication |
Different Units By MoH Code
Rasilez HCT 300mg/25mg° MoH 5651 :
Form | Tablet, Film-Coated |
Package Size | Box of 28 |
Strength | 300mg/25mg |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 218327/09 |
Submission date | 01/01/2009 |
Registration Year | 2010 |
Archived Date | 2017 |
Withdrawn Date | 04/05/2021 |
Price Comparison
● Country: | Abu Dhabi | |
● Package Size: | 28 | |
● Public Price: | 158.5 AED | ( 3,829,518.50 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 5,6607 AED | ( 120,805.00 LBP ) |
● Pharmacy Price: | 127.55 AED | ( 3081735.55 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 28's (7's Blister x 4) | |
● Public Price: | 158.5 AED | ( 3,829,518.50 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 5,6607 AED | ( 120,805.00 LBP ) |
● Pharmacy Price: | 127.55 AED | ( 3081735.55 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 28 | |
● Public Price: | 46.35 CHF | ( 4,793,517.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,6554 CHF | ( 103,420.00 LBP ) |
● Exfactory Price: | 26.09 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 28 | |
● Public Price: | 29.91 EUR | ( 2,897,561.16 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,0682 EUR | ( 96,876.00 LBP ) |
● Pharmacy Price: | 22.91 EUR | ( 2219429.16 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 28 TABS | |
● Public Price: | 31.72 EUR | ( 3,072,906.72 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,1329 EUR | ( 96,876.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 28 | |
● Public Price: | 124.4 SAR | ( 2,940,816.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 4,4429 SAR | ( 94,560.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
● Country: | France | |
● Package Size: | 30 | |
● Public Price: | 20.42 EUR | ( 1,978,207.92 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,6807 EUR | ( 0.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Ireland | |
● Package Size: | 28 | |
● Public Price: | 22.88 EUR | ( 2,216,522.88 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,8171 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 21 EUR | |
● Pricing Date: | 01/08/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Belgium | |
● Package Size: | 98 | |
● Public Price: | 93.22 EUR | ( 9,030,780.72 LBP ) |
● Pack size unit used: | 98 | |
● Cost/Unit: | 0,9512 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 22/06/2017 | |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File